Mizuho Medy Co Ltd
TSE:4595
Intrinsic Value
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. [ Read More ]
The intrinsic value of one Mizuho Medy Co Ltd stock under the Base Case scenario is 2 566.74 JPY. Compared to the current market price of 2 289 JPY, Mizuho Medy Co Ltd is Undervalued by 11%.
Valuation Backtest
Mizuho Medy Co Ltd
Run backtest to discover the historical profit from buying and selling Mizuho Medy Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Mizuho Medy Co Ltd
Current Assets | 16.3B |
Cash & Short-Term Investments | 10.1B |
Receivables | 4.4B |
Other Current Assets | 1.8B |
Non-Current Assets | 2.7B |
Long-Term Investments | 8m |
PP&E | 2.3B |
Intangibles | 11.9m |
Other Non-Current Assets | 387m |
Current Liabilities | 2.3B |
Accounts Payable | 512.2m |
Accrued Liabilities | 296.2m |
Other Current Liabilities | 1.5B |
Non-Current Liabilities | 992.9m |
Other Non-Current Liabilities | 992.9m |
Earnings Waterfall
Mizuho Medy Co Ltd
Revenue
|
11B
JPY
|
Cost of Revenue
|
-2.9B
JPY
|
Gross Profit
|
8.1B
JPY
|
Operating Expenses
|
-2.9B
JPY
|
Operating Income
|
5.2B
JPY
|
Other Expenses
|
-1.4B
JPY
|
Net Income
|
3.8B
JPY
|
Free Cash Flow Analysis
Mizuho Medy Co Ltd
Profitability Score
Profitability Due Diligence
Mizuho Medy Co Ltd's profitability score is 85/100. The higher the profitability score, the more profitable the company is.
Score
Mizuho Medy Co Ltd's profitability score is 85/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Mizuho Medy Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Mizuho Medy Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Mizuho Medy Co Ltd
Shareholder Return
Price
Mizuho Medy Co Ltd
Average Annual Return | -6.37% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -66% |
Market Capitalization | 34.4B JPY |
Shares Outstanding | 15 021 115 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
Contact
IPO
Employees
Officers
The intrinsic value of one Mizuho Medy Co Ltd stock under the Base Case scenario is 2 566.74 JPY.
Compared to the current market price of 2 289 JPY, Mizuho Medy Co Ltd is Undervalued by 11%.